Kingsley I. Ndoh on the power of AI in advancing personalized cancer care at WCC

Kingsley I. Ndoh, Clincial Assistant Professor, Global Health at University of Washington, shared on LinkedIn:

“I just returned from the Union for International Cancer Control (UICC) World Cancer Congress in Geneva, Switzerland, where I had the honor of delivering a keynote plenary to share our vision on the transformative power of AI in advancing personalized cancer care, and Hurone AI‘s progress in implementing our solutions across Brazil, Nigeria, and Kenya. Including our collaboration with University of California, San Francisco Brain Tumor Center. It was also a privilege to participate in the “Big Debate” on the progress and perils of AI in cancer care—a topic at the core of what we do.

I shared our vision with leading cancer experts and global leaders on how our technology will transform oncology and make personalized cancer care accessible to everyone, everywhere.

Excitingly, I announced our new agreement with the NATIONAL CANCER INSTITUTE OF KENYA, where Hurone AI will first be adopted in two cancer centers and then scale to 10 regional cancer centers, reaching over 40,000 patients within the next year—a huge milestone in our mission to revolutionize cancer care worldwide. We are especially thankful for DR. ELIAS MELLY, M.D visionary leadership in leveraging technology backed by Government funding to transform cancer care in Kenya.

It was also wonderful catching up with one of my mentors, Julie Gralow, VP and Chief Medical Officer at the American Society of Clinical Oncology (ASCO) and glean from her wealth of wisdom, and reconnecting with Miriam Mutebi, MD,MSc,FACS, President of AORTIC- Africa one of Hurone AI’s strongest allies in Kenya.

None of this would have been possible without the incredible dedication and innovation of the Hurone AI team. Their hard work and commitment to our mission have been pivotal in driving these achievements forward.

A special thanks to our board advisor, Irene Dankwa-Mullan MD MPH, for her presence and invaluable insights throughout the conference.

The momentum is strong, and I’m excited to continue driving innovation in cancer care through AI. Stay tuned—there’s much more to come.”

Source:Kingsley I. Ndoh/LinkedIn